Theravance Biopharma, Inc. (TBPH) Gross margin 2016–2017
Theravance Biopharma, Inc. (TBPH) gross margin by fiscal year — reported gross profit divided by reported revenue.
60.8%FY2017 · since FY2016: 94.1% → 60.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2017 | 60.8% | -33.2 pp |
| FY2016 | 94.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice